Selected research
Market Structure
Global Gemcitabine Powder For Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gemcitabine Powder For Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gemcitabine Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gemcitabine Powder For Injection include Jiangsu Hansoh Pharmaceutical Group, Pfizer, Harbin Pharmaceutical Group, Strides Pharma Science Limited, Getwell Pharmaceuticals, Eli Lilly and Company, DRUG INTERNATIONAL LTD and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Gemcitabine Powder For Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gemcitabine Powder For Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gemcitabine Powder For Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gemcitabine Powder For Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Gemcitabine Powder For Injection Segment by Company
Jiangsu Hansoh Pharmaceutical Group
Pfizer
Harbin Pharmaceutical Group
Strides Pharma Science Limited
Getwell Pharmaceuticals
Eli Lilly and Company
DRUG INTERNATIONAL LTD
Accord Healthcare
Gemcitabine Powder For Injection Segment by Type
1 g
2 g
200 mg
Gemcitabine Powder For Injection Segment by Application
Geriatric Use
Pediatric Use
Adult Use
Gemcitabine Powder For Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gemcitabine Powder For Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gemcitabine Powder For Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gemcitabine Powder For Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Gemcitabine Powder For Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gemcitabine Powder For Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gemcitabine Powder For Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Gemcitabine Powder For Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 1 g
- 2 g
- 200 mg
Applications
- Geriatric Use
- Pediatric Use
- Adult Use
Companies covered
- Jiangsu Hansoh Pharmaceutical Group
- Pfizer
- Harbin Pharmaceutical Group
- Strides Pharma Science Limited
- Getwell Pharmaceuticals
- Eli Lilly and Company
- DRUG INTERNATIONAL LTD
- Accord Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Gemcitabine Powder For Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Gemcitabine Powder For Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Gemcitabine Powder For Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Gemcitabine Powder For Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Gemcitabine Powder For Injection Market Dynamics
- 2.1 Gemcitabine Powder For Injection Industry Trends
- 2.2 Gemcitabine Powder For Injection Industry Drivers
- 2.3 Gemcitabine Powder For Injection Industry Opportunities and Challenges
- 2.4 Gemcitabine Powder For Injection Industry Restraints
3 Gemcitabine Powder For Injection Market by Manufacturers
- 3.1 Global Gemcitabine Powder For Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Gemcitabine Powder For Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Gemcitabine Powder For Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Gemcitabine Powder For Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Gemcitabine Powder For Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Gemcitabine Powder For Injection Manufacturers, Product Type & Application
- 3.7 Global Gemcitabine Powder For Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Gemcitabine Powder For Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Gemcitabine Powder For Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Gemcitabine Powder For Injection Tier 1, Tier 2, and Tier 3
4 Gemcitabine Powder For Injection Market by Type
- 4.1 Gemcitabine Powder For Injection Type Introduction
- 4.1.1 1 g
- 4.1.2 2 g
- 4.1.3 200 mg
- 4.2 Global Gemcitabine Powder For Injection Sales by Type
- 4.2.1 Global Gemcitabine Powder For Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Gemcitabine Powder For Injection Sales by Type (2021-2032)
- 4.2.3 Global Gemcitabine Powder For Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Gemcitabine Powder For Injection Revenue by Type
- 4.3.1 Global Gemcitabine Powder For Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Gemcitabine Powder For Injection Revenue by Type (2021-2032)
- 4.3.3 Global Gemcitabine Powder For Injection Revenue Market Share by Type (2021-2032)
5 Gemcitabine Powder For Injection Market by Application
- 5.1 Gemcitabine Powder For Injection Application Introduction
- 5.1.1 Geriatric Use
- 5.1.2 Pediatric Use
- 5.1.3 Adult Use
- 5.2 Global Gemcitabine Powder For Injection Sales by Application
- 5.2.1 Global Gemcitabine Powder For Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Gemcitabine Powder For Injection Sales by Application (2021-2032)
- 5.2.3 Global Gemcitabine Powder For Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Gemcitabine Powder For Injection Revenue by Application
- 5.3.1 Global Gemcitabine Powder For Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Gemcitabine Powder For Injection Revenue by Application (2021-2032)
- 5.3.3 Global Gemcitabine Powder For Injection Revenue Market Share by Application (2021-2032)
6 Global Gemcitabine Powder For Injection Sales by Region
- 6.1 Global Gemcitabine Powder For Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Gemcitabine Powder For Injection Sales by Region (2021-2032)
- 6.2.1 Global Gemcitabine Powder For Injection Sales by Region (2021-2026)
- 6.2.2 Global Gemcitabine Powder For Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Gemcitabine Powder For Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Gemcitabine Powder For Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Gemcitabine Powder For Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Gemcitabine Powder For Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Gemcitabine Powder For Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Gemcitabine Powder For Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Gemcitabine Powder For Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Gemcitabine Powder For Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Gemcitabine Powder For Injection Revenue by Region
- 7.1 Global Gemcitabine Powder For Injection Revenue by Region
- 7.1.1 Global Gemcitabine Powder For Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Gemcitabine Powder For Injection Revenue by Region (2021-2026)
- 7.1.3 Global Gemcitabine Powder For Injection Revenue by Region (2027-2032)
- 7.1.4 Global Gemcitabine Powder For Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Gemcitabine Powder For Injection Revenue (2021-2032)
- 7.2.2 North America Gemcitabine Powder For Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Gemcitabine Powder For Injection Revenue (2021-2032)
- 7.3.2 Europe Gemcitabine Powder For Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Gemcitabine Powder For Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Gemcitabine Powder For Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Gemcitabine Powder For Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Gemcitabine Powder For Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Jiangsu Hansoh Pharmaceutical Group
- 8.1.1 Jiangsu Hansoh Pharmaceutical Group Company Information
- 8.1.2 Jiangsu Hansoh Pharmaceutical Group Business Overview
- 8.1.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Powder For Injection Product Portfolio
- 8.1.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Gemcitabine Powder For Injection Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Harbin Pharmaceutical Group
- 8.3.1 Harbin Pharmaceutical Group Company Information
- 8.3.2 Harbin Pharmaceutical Group Business Overview
- 8.3.3 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Harbin Pharmaceutical Group Gemcitabine Powder For Injection Product Portfolio
- 8.3.5 Harbin Pharmaceutical Group Recent Developments
- 8.4 Strides Pharma Science Limited
- 8.4.1 Strides Pharma Science Limited Company Information
- 8.4.2 Strides Pharma Science Limited Business Overview
- 8.4.3 Strides Pharma Science Limited Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Strides Pharma Science Limited Gemcitabine Powder For Injection Product Portfolio
- 8.4.5 Strides Pharma Science Limited Recent Developments
- 8.5 Getwell Pharmaceuticals
- 8.5.1 Getwell Pharmaceuticals Company Information
- 8.5.2 Getwell Pharmaceuticals Business Overview
- 8.5.3 Getwell Pharmaceuticals Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Getwell Pharmaceuticals Gemcitabine Powder For Injection Product Portfolio
- 8.5.5 Getwell Pharmaceuticals Recent Developments
- 8.6 Eli Lilly and Company
- 8.6.1 Eli Lilly and Company Company Information
- 8.6.2 Eli Lilly and Company Business Overview
- 8.6.3 Eli Lilly and Company Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Eli Lilly and Company Gemcitabine Powder For Injection Product Portfolio
- 8.6.5 Eli Lilly and Company Recent Developments
- 8.7 DRUG INTERNATIONAL LTD
- 8.7.1 DRUG INTERNATIONAL LTD Company Information
- 8.7.2 DRUG INTERNATIONAL LTD Business Overview
- 8.7.3 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 DRUG INTERNATIONAL LTD Gemcitabine Powder For Injection Product Portfolio
- 8.7.5 DRUG INTERNATIONAL LTD Recent Developments
- 8.8 Accord Healthcare
- 8.8.1 Accord Healthcare Company Information
- 8.8.2 Accord Healthcare Business Overview
- 8.8.3 Accord Healthcare Gemcitabine Powder For Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Accord Healthcare Gemcitabine Powder For Injection Product Portfolio
- 8.8.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Gemcitabine Powder For Injection Value Chain Analysis
- 9.1.1 Gemcitabine Powder For Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Gemcitabine Powder For Injection Production Mode & Process
- 9.2 Gemcitabine Powder For Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Gemcitabine Powder For Injection Distributors
- 9.2.3 Gemcitabine Powder For Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst